|
LOC283267 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.350300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.764500E-02 |
| Normal-vs-Stage2 |
8.737900E-03 |
| Normal-vs-Stage3 |
1.760220E-02 |
| Normal-vs-Stage4 |
2.749400E-01 |
| Stage1-vs-Stage2 |
7.772500E-02 |
| Stage1-vs-Stage3 |
2.037800E-01 |
| Stage1-vs-Stage4 |
9.964600E-01 |
| Stage2-vs-Stage3 |
4.806600E-01 |
| Stage2-vs-Stage4 |
1.938420E-01 |
| Stage3-vs-Stage4 |
4.145000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.665680E-02 |
| Normal-vs-AfricanAmerican |
8.511000E-01 |
| Normal-vs-Asian |
6.751000E-01 |
| Caucasian-vs-AfricanAmerican |
1.109780E-01 |
| Caucasian-vs-Asian |
1.527440E-01 |
| AfricanAmerican-vs-Asian |
6.318800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.922000E-01 |
| Normal-vs-Female |
1.440450E-02 |
| Male-vs-Female |
3.160400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.286800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.397600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.180100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.300240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.092200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.511500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.684600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.883000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.035600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.455800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.961830E-01 |
| Classical-VS-Follicular |
1.903150E-03 |
| Classical-VS-Other |
5.733800E-01 |
| Classical-VS-Normal |
2.709200E-01 |
| Tall-VS-Follicular |
4.276800E-01 |
| Tall-VS-Other |
9.144600E-01 |
| Tall-VS-Normal |
3.660400E-02 |
| Follicular-VS-Other |
6.502800E-01 |
| Follicular-VS-Normal |
1.164230E-03 |
| Other-VS-Normal |
2.724400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.062800E-03 |
| Normal-vs-N1 |
5.749800E-02 |
| N0-vs-N1 |
5.880800E-01 |
|
|
